Figure 6From: In vivo efficacy of the histone deacetylase inhibitor suberoylanilide hydroxamic acid in combination with radiotherapy in a malignant rhabdoid tumor mouse modelH&E, TUNEL and Ki67 staining of tumor tissue from MRT xenografts treated with vehicle, suberoylanilide hydroxamic acid (SAHA), ionizing radiation (XRT) or SAHA and XRT. See also Table 1.Back to article page